Highlights from the opening day of the 2014 European Huntington's Disease network in Barcelona, Spain
Does tau protein – which causes problems in other neurodegenerative diseases – contribute to Huntington's disease?
Some unexpected findings suggest new ways to aim at an old target in HD
The largest ever HD drug trial, testing coenzyme Q10, is halted for 'futility'. What does that mean for HD research?
Brain cells called astrocytes might play a bigger role than previously thought in Huntington's disease
Can drug trials that fail be helpful? A HD mouse study provides solid evidence of an approach that doesn't help HD
Researchers have used mice with glowing brain cells to decipher the first steps of neurodegeneration
A long-term study of the brains of HD patients who received grafts of fetal tissue reveals a surprising result
An important new study asks the question: what parts of the brain might need most help in HD?
NUB1 increases mutant huntingtin removal from cells, reducing the toxic effects of HD in fruit flies
Does a specific amino acid deficiency contribute to the development of HD?